MARY JANE SORENSON: Open Payments
NPI 1851870919 · SHOW LOW, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 26 payments from 12 companies in 2025. Trend: 2023 $392 · 2024 $490 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Novo Nordisk Inc | 4 | $65 |
| Exact Sciences Corporation | 3 | $61 |
| PFIZER INC. | 3 | $50 |
| Astellas Pharma US Inc | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Insulet Corporation | 1 | $28 |
| Grifols USA, LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: GEMTESA, Cologuard Collection Kit, Ozempic, Veozah, ELIQUIS, BREZTRI, Omnipod, Prolastin-C Liquid.
Industry payments across AZ — which companies pay providers there.
